Lefitolimod: Phase I started

Mologen said the University of Texas MD Anderson Cancer Center began an open-label, dose-escalation, dose-expansion, U.S. Phase

Read the full 177 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE